The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency: Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?

RATIONALE: The use of cisplatin in patients with chronic kidney disease (CKD) is risky and depends on a number of factors. The optimal procedure in stage I of a non seminomatous germ cell tumor without proven lymphangioinvasion after orchiectomy is controversial and is the subject of a number of dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Pokrivcak, Tomas, Lakomy, Radek, Kazda, Tomas, Poprach, Alexandr, Fabian, Pavel, Kiss, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213256/
https://www.ncbi.nlm.nih.gov/pubmed/34128899
http://dx.doi.org/10.1097/MD.0000000000026381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213256/
https://www.ncbi.nlm.nih.gov/pubmed/34128899
http://dx.doi.org/10.1097/MD.0000000000026381

Ejemplares similares